Abstract

Type 2 Diabetes (T2D) Female Case with Clinical Efficacy of Vildaglipin, Metformin and Imeglimin

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Clinical efficacy and prognosis of acarbose and metformin in the treatment of type 2 diabetes mellitus patients with coronary heart disease
...
International Urology and Nephrology | VOL. 37
, et. al. ...
15 Nov 2017
Efficacy of metformin monotherapy in US veterans with type 2 diabetes and preexisting chronic kidney disease stage 3
Darren E. Gemoets ... Aidar R. Gosmanov
Diabetes, Obesity and Metabolism | VOL. 23
Darren E. Gemoets, et. al.Darren E. Gemoets ... Aidar R. Gosmanov
14 May 2021
Clinical efficacy of metformin combined with sitagliptin or pioglitazone in treatment of type 2 diabetes mellitus
-
01 Dec 2013
Meta-analysis: The efficacy of metformin and other anti-hyperglycemic agents in prolonging the survival of hepatocellular carcinoma patients with type 2 diabetes
Xuefen Lei ... Fan Ni
Annals of Hepatology | VOL. 19
Xuefen Lei, et. al.Xuefen Lei ... Fan Ni
16 Dec 2019
View more papers

More From: International Journal of Endocrinology and Diabetes

Paper Title
Journal
Date
Author
-
-
International Journal of Endocrinology and Diabetes | VOL. 7
--
15 May 2024
Metformin as First-Line Agent for Type 2 Diabetes (T2D) with Various Beneficial Aspect
-
International Journal of Endocrinology and Diabetes | VOL. 7
--
15 May 2024
Type 2 Diabetes (T2D) Female Case with Clinical Efficacy of Vildaglipin, Metformin and Imeglimin
-
International Journal of Endocrinology and Diabetes | VOL. -
--
06 May 2024
-
-
International Journal of Endocrinology and Diabetes | VOL. 7
--
06 May 2024
View more papers